OKYO Pharma annual free cash flow
2021
2022
2023
2025
2026
OKYO Pharma Free Cash Flow (FCF) History (OKYO)
OKYO Pharma reported −$5.9M in free cash flow for fiscal 2026, a decrease of $4.1M from the previous fiscal year.
View full OKYO Pharma company overviewOKYO Pharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2026 | 2026-03-31 | −$5.9M | −$4.1M | — | — |
| 2025 | 2025-03-31 | −$1.8M | — | — | — |
| 2023 | 2023-03-31 | −$7.7M | −$2.2M | — | — |
| 2022 | 2022-03-31 | −$5.5M | −$3.9M | — | — |
| 2021 | 2021-03-31 | −$1.6M | — | — | — |
OKYO Pharma free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$1.6M to −$5.9M, a net decrease of $4.3M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review OKYO Pharma source filings ↗